NCT01474473View on ClinicalTrials.gov

Efficacy Of CACIPLIQ20 On Diabetic Ulcers In Patients Wearing An Nonremovable, Windowed, Fiberglass Cast Boot

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

January 31, 2014

Study Completion Date

March 31, 2014

Conditions
Foot UlcerDiabetes MellitusDiabetic Neuropathy
Interventions
DEVICE

CACIPLIQ20 and Nonremovable, Windowed, Fiberglass Cast Boot

"The Nonremovable, Windowed, Fiberglass Cast Boot is implemented before the beginning of CACIPLIQ20 treatment and is maintained during the treatment.~CACIPLIQ20 is applied on the wound for 10 minutes every 3 to 4 days"

DEVICE

Placebo and Nonremovable, Windowed, Fiberglass Cast Boot

"The Nonremovable, Windowed, Fiberglass Cast Boot is implemented before the beginning of placebo treatment and is maintained during the treatment.~Placebo is applied on the wound for 10 minutes every 3 to 4 days"

Trial Locations (1)

75013

Pitié-Salpêtrière Hospital, Paris

All Listed Sponsors
lead

Organ, Tissue, Regeneration, Repair and Replacement

INDUSTRY

NCT01474473 - Efficacy Of CACIPLIQ20 On Diabetic Ulcers In Patients Wearing An Nonremovable, Windowed, Fiberglass Cast Boot | Biotech Hunter | Biotech Hunter